Semaglutide War Heats Up: Eli Lilly’s Patrik Jonsson On India Market Shake-Up
Eli Lilly's Exec VP Patrik Jonsson joins CNBC-TV18 to address the intensifying semaglutide competition in India's booming obesity drug market. With the patent expiring soon, generics from Indian firms like Dr Reddy's and Sun Pharma are set to slash prices, shaking up the landscape dominated by Lilly's Mounjaro and Novo's Ozempic/Wegovy. #weightlossdrugs #obesity #pharma #healthcare #ozempic #wegovy #mounjaro #glp1 #indiapharma #healthnews #drugpricing #fitnessindia #wellness #medicalnews #pharmasection #healthupdate #cnbctv18 🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ SUBSCRI…